Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.18 USD | +1.46% | -3.02% | -39.04% |
26/04 | European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4% | MT |
17/04 | Evaxion Announces Phase 2 Clinical Trial Update | CI |
Evolution of the average Target Price on Evaxion Biotech A/S
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Evaxion Biotech A/S
Ladenburg Thalmann | |
HC Wainwright | |
Lake Street | |
Oppenheimer |
EPS Revisions
- Stock Market
- Equities
- EVAX Stock
- Consensus Evaxion Biotech A/S